Company Search:
Advanced Search
Sponsored Links
Mitsubishi Tanabe Pharma Corp Company Snapshot
Mitsubishi Tanabe Pharma Corp operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mitsubishi Tanabe Pharma Corp with three other companies in this sector in Japan: Taisho Pharmaceutical Holdings Co Ltd (2018 sales of 280.09 billion Japanese Yen [US$2.48 billion] of which 66% was Self-medication), Shionogi & Co Ltd (344.67 billion Japanese Yen [US$3.05 billion] of which 100% was Pharmaceuticals), and Eisai Company Limited (600.05 billion Japanese Yen [US$5.32 billion] of which 49% was Pharmaceutical Business -Japan).

Sales Analysis. During the year ended March of 2018, sales at Mitsubishi Tanabe Pharma Corp were ¥433.86 billion (US$3.84 billion). This is an increase of 2.3% versus 2017, when the company's sales were ¥423.98 billion. The sales level in 2018 was fairly close to the level five years ago: in 2013, Mitsubishi Tanabe Pharma Corp had sales of ¥419.18 billion. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 113.9% in 2018, from ¥1.42 billion to ¥3.03 billion. Mitsubishi Tanabe Pharma Corp also saw significant increases in sales in Overseas Ethical Drug (up 70.0% to ¥38.57 billion) and General Drug (up 9.3% to ¥3.73 billion) . Not all segments of Mitsubishi Tanabe Pharma Corp experienced an increase in sales in 2018: sales of Royalty Incomes fell 3.8% to ¥79.15 billion. Mitsubishi Tanabe Pharma Corp also experienced decreases in sales in Domestic Ethical Drug (down 1.5% to ¥309.37 billion) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Mitsubishi Tanabe Pharma Corp
  Stock Performance Chart for Mitsubishi Tanabe Pharma Corp
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 1,683.00
(Figures in Japanese Yen)
1 Week -3.4%   13 Weeks -0.4%  
4 Weeks -6.4%   52 Weeks -29.8%  
Mitsubishi Tanabe Pharma Corp Key Data:
  Ticker: 4508 Country: Japan
  Exchanges: TYO OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 433,855,000,000
(Year Ending Jan 2019).
Employees: 7,187
  Currency: Japanese Yen Market Cap: 943,788,843,855
  Fiscal Yr Ends: March Shares Outstanding: 560,777,685
  Share Type: Common Closely Held Shares: 323,238,416
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.